Sculptor Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-150,000
Closed -$19.8M 381
2017
Q2
$19.8M Buy
+150,000
New +$19.1M 0.11% 112
2015
Q1
Sell
-946,700
Closed -$99M 599
2014
Q4
$99M Buy
946,700
+50,000
+6% +$5.27M 0.27% 88
2014
Q3
$95.6M Buy
896,700
+20,000
+2% +$2.07M 0.28% 80
2014
Q2
$91.7M Buy
876,700
+50,000
+6% +$5.05M 0.27% 94
2014
Q1
$81.2M Sell
826,700
-2,579,900
-76% -$239M 0.27% 91
2013
Q4
$312M Buy
3,406,600
+81,900
+2% +$7.55M 0.8% 23
2013
Q3
$288M Buy
3,324,700
+421,700
+15% +$37.8M 0.82% 21
2013
Q2
$249M Buy
+2,903,000
New +$246M 0.78% 24

Other funds holding JNJ

Sculptor Capital's JNJ Position: Q1 2015 in Review

Sculptor Capital sold out of Johnson & Johnson (JNJ) in Q1 2015, closing a stake of 113,177 shares — an estimated $11.8M sold.

Sculptor Capital first reported a position in JNJ in Q3 2013 and held it in 5 quarters. The position peaked at $19.8M in Q4 2013. 2,102 funds tracked by Wall St. Rank hold JNJ as of Q1 2015.

  • Sculptor Capital reported no remaining Johnson & Johnson position as of Q1 2015 after selling out during the quarter.
  • Sculptor Capital sold 113,177 Johnson & Johnson shares in Q1 2015, an estimated $11.8M.
  • Sculptor Capital first reported a position in Johnson & Johnson in Q3 2013 and held it in 5 quarters.
  • Sculptor Capital's Johnson & Johnson position peaked at $19.8M in Q4 2013.
  • 2,102 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2015.

Based on Sculptor Capital's 13F filing for Q1 2015, filed 15 May 2015.